Lisa Lewin, Author at Precision Value & Health

Conference: Precision Attends HLTH, 2023

Lisa Lewin2023-10-26T13:22:56+00:00Events, Thought Leadership|

Precision will be at HLTH 2023, October 8 – 11, in Las Vegas, NV. Connect with our team of experts as they lead meaningful discussions and attend networking events focused on innovation and transformation for better patient health and treatment outcomes.

Connect with one our experts!

Schedule a meeting with one our our experts by emailing precisionadvance@precisionmedicinegrp.com
Join Precision’s Ashwin Athri: EVP, Strategy, Innovation, and Partnerships (Precision Value & Health) for an insightful panel session on Sunday, October 8th titled, “Digital Deliberations: The Ins and Outs of Implementing a Digital Strategy”

(more…)

Conference: Association for Value-Based Cancer Care 2023 Educational Summit & Program

Lisa Lewin2023-10-18T18:22:19+00:00Events, Thought Leadership|

Precision’s Phil Cyr will be the presenting at this year’s Association for Value-Based Cancer Care 2023 Educational Summit & Program, October 18 – 20, NYC, NY. This exclusive invitational forum provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem.

Don’t miss an opportunity to celebrate groundbreaking science and network with industry leaders!

Be sure to attend Precision’s own, Phil Cyr’s presentation on October 18th, 2023, at 10:00 AM ET

You can register for the Association for Value-Based Cancer Care 2023 Educational Summit & Program:

REGISTER HERE

(more…)

Conference: Meeting on the Mesa, 2023

Lisa Lewin2023-10-18T18:24:25+00:00Events, Thought Leadership|

Precision will be at this year’s Meeting on the Mesa, October 10-12, 2023, in Carlsbad, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for cell and gene therapies.

Connect with our Advanced Therapy experts

Visit us through any of the numerous networking opportunities at Meeting on the Mesa 23′
Be sure to attend the ADVANCE sponsored Plenary Session on October 10, 2023, 9:30 – 10:30 AM PT |Location: Park Hyatt Aviara (Aseptic Technologies Ballroom)
Join us for the ADVANCE sponsored Cocktail Reception on October 11, 2023, 6:00-7:00 PM PT

You can register for Meeting on the Mesa below:

REGISTER HERE

(more…)

Download Now: Precision September Events Calendar

Lisa Lewin2023-10-26T18:34:46+00:00Events, Thought Leadership|

The PV&H September Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!

See the September events calendar here!

Article: The Role of the Pharma Industry in Superseding Outdated Medical Practices

Lisa Lewin2023-08-31T22:06:35+00:00Thought Leadership|

There has been and continues to be a surge in biotech innovation. But a pertinent question arises: how frequently are older, now outdated technologies phased out? Precision’s Ross Maclean, Phil Cyr and Ray Roth discuss the reluctance to abandon practices and technologies despite the availability of newer, better alternatives, and list how biopharma can lead the way.

Article: What’s Behind the Slow Uptake of Biosimilars in the US?

Lisa Lewin2023-10-26T19:10:03+00:00Thought Leadership|

Payers have long maintained that the high cost of biologics relative to small-molecule drugs is unsustainable and a threat to their business model. However, a new analysis shows that many plans aren’t yet sold on giving less expensive biosimilars better footing on formularies compared to reference products.

READ THE ARTICLE HERE!

White Paper: The Price is Right: Cell and Gene Therapy Approvals and Market Access in 2023

Lisa Lewin2023-10-31T13:27:22+00:00Thought Leadership|

Starting health economic evidence development and market access planning as early as possible in clinical development for a cell and gene therapy is important demonstrating the value to payers and health technology appraisal (HTA) organizations. In a dynamic regulatory and market access landscape, balancing the requirements of regulators and the expectations of payors can be challenging since there is no one-size-fits-all approach.

(more…)

Conference: CAR-TCR Summit, 2023

Lisa Lewin2023-10-31T13:30:32+00:00Events, Thought Leadership|

Precision will be at this year’s CAR-TCR Summit August 29 – September 1, 2023, in Boston, MA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization of cell therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below.

Precision ADVANCE will hold a welcome reception on August 29, 2023, at 5:30 pm.
Project Farma will be facilitating a Manufacturing track panel discussion “Keys to Success for a Commercial – Ready Cell Therapy Facility” on August 30, 2023, 4:30 – 5:00 pm.
Precision ADVANCE will be facilitating an Early-Stage Clinical Strategy track panel discussion “Strategies for Successful Clinical Development of Cell Therapies” on August 30, 2023, 4:30 – 5:00 pm.
Precision ADVANCE will have a plenary speaking position “The Journey of Commercializing Cell Therapies” on August 31, 2023, 8:05 – 8:50 am.

Connect with our Advanced Therapy experts

Visit us at booth 90 in the exhibition area
Schedule in-person or virtual meetings with one of our experts
Attend our ADVANCE-sponsored Welcome Reception on August 29, 2023, at 5:30 PM ET

(more…)

White Paper: Cell and Gene Therapies: How High Can Prices Go?

Lisa Lewin2023-10-31T20:53:05+00:00Thought Leadership|

The concept of optimizing CGT value propositions begs the question of what is reasonable when it comes to breakthrough science and unprecedented therapeutic solutions. Can a $5 million price tag be justified? What about $10 million?

This white paper is based on a webinar convened by PRECISIONadvisors, focusing on cell and gene therapy (CGT) pricing. The webinar featured two in-house experts from the PRECISIONadvisors Global Pricing & Market Access practice: Richard Macaulay, Senior Vice President and David Carr, Senior Director.

(more…)

White Paper: The Future is Now: Cell and Gene Therapy Innovation, Challenges, and Perspectives

Lisa Lewin2023-11-06T18:37:00+00:00Thought Leadership|

Cell and gene therapies have the potential to revolutionize treatment of a wide range of diseases. With six new therapies approved in 2022, including the first allogeneic T-cell therapy, and at least as many slated for approval this year, the sector is poised for rapid growth. This innovation comes with challenges, though, and many consider 2023 to be a seminal year for establishing a strong foothold for advanced therapies in mainstream medicine.

(more…)

About Lisa Lewin